FDA Inspection 865905 — Ohlsen Pharmacal Company

Ohlsen Pharmacal Company — FEI 1946569

The FDA completed an inspection of Ohlsen Pharmacal Company on Feb 10, 2014 in Washington, MO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 18 citations were issued during this inspection. Product area: Food/Cosmetics.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 10, 2014
Fiscal Year
2014
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Washington, MO (United States)

Citations

IDCFRDescription
1538221 CFR 111.8Written procedures - personnel qualifications
1540221 CFR 111.12Personnel - quality control personnel - qualified
1540421 CFR 111.12(c)Personnel - education, training, experience
1544721 CFR 111.15(c)(3)Cleaning compounds and toxic materials - holding
1554321 CFR 111.260(c)Batch record - date, time; maintenance
1555921 CFR 111.260(k)(1)Batch record - identifier; labels
1556021 CFR 111.260(k)(2)Batch record - label
1558121 CFR 111.155(c)(3)Quality control - components, approve, release
1558521 CFR 111.155(d)(2)Components - unique identifier
1560421 CFR 111.165(b)Product received - visually examine invoice, guarantee, cert
1563421 CFR 111.180(b)(3)(ii)(D)Documentation - required operation; material review, disposi
1573621 CFR 111.353Manufacturing operations - written procedures
1576221 CFR 111.205(a)Master manufacturing record - each batch
1580921 CFR 111.570(b)(1)Written procedures - product complaint; review, investigate
1592721 CFR 111.103Written procedures - quality control operations
1598421 CFR 111.123(a)(8)Quality control - finished batch, distribution
1604621 CFR 111.503Written procedures returned dietary supplement investigation
1606621 CFR 111.35(b)(1)(i)Written procedures - instruments, controls; calibrating